Clinical trial

A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

NCT04955834

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Insulin degludec injection Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tresiba® Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-07-27

PhasePHASE3

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

Insulin degludec injectionDRUG

Tresiba®DRUG

Sponsors & collaborators

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.lead sponsor

Mapped research locations

ChangshaHunan, China1 ChongqingChongqing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04955834 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.